Title for MeetingAbstracts
Alphabetical listing of titles
Antibodies to SIVmac(K1) envelope-derived synthetic peptides identify shared antigenic determinants from related primate immunodeficiency virus isolates.
Antibodies to structural and nonstructural polypeptides of D-type retrovirus in patients with AIDS.
Antibodies to sulfamethoxazole (SMX) in normal, allergic, HIV infected, and AIDS patients.
Antibodies to the gp120 principal neutralizing domain of the HIV-MN strain (gp120-MN-PND) as predictors of materno-fetal transmission.
Antibodies to the Tip Adhesin Protein of H. influenzae LKP Pili Prevent Bacterial Adhesion to Human Erythrocytes.
Antibodies which recognize both conserved and variable regions of HIV-1 GP-120 are responsible for HIV-specific ADCC.
Antibody (Ab) Response to an 11-valent Pneumococcal (Pnc) Conjugate Vaccine in Filipino, Finnish and Israeli Infants.
Antibody and cytokine profiles in semen from subjects with primary and chronic HIV-1 infections.
Antibody binding of p24 antigen: relationship to risk of AIDS.
Antibody Blocking of DC-SIGN/DC-SIGNR Interaction with HIV and Ebola Glycoproteins.
Antibody characterization and virus load of long-term asymptomatic HIV-1 infected individuals.
Antibody characterization of seropositive individuals without immunological abnormalities and not progressing to clinical manifestations of HIV-1 infection.
Antibody dependent cell-mediated cytotoxicity (ADCC) in relation to clinical progression of HIV-1 associated disease in haemophiliacs.
Antibody dependent cell-mediated cytotoxicity against HIV gp120 in cervical fluids of HIV positive women.
Antibody dependent cell-mediated cytotoxicity in HIV+ children.
Antibody dependent cellular cytotoxicity (ADCC) following vaccination with a recombinant HIV-1 gp160 vaccine.
Antibody dependent cellular cytotoxicity (ADCC) in blood and cerebrospinal fluid (CSF) of HIV-1 infected Zairian patients.
Antibody dependent enhancement and neutralization pattern of sera of SIV infected or HIV2 vaccinated rhesus monkeys.
Antibody dependent enhancement of HIV-1 infection in T-cells by anti-anti-CD4 antibodies is FcR- and C3R-independent.
Antibody dependent enhancement of HIV-1 infection requires CD4 receptor and FcR or II.
Antibody enhancement and vertical transmission of HIV.
Antibody from Patients with Acute HIV Infection Inhibits Primary Strains of HIV-1 in the Presence of Natural Killer Effector Cells.
Antibody levels and IgG avidity after primary immunization to H. influenzae type b and measles in HIV infected children on HAART.
Antibody Neutralization and Escape by HIV-1.
Antibody Neutralization Escape Mediated by Point Mutations in the Intracytoplasmic Domain of HIV-1 GP41.
Antibody Persistence 9 Years after Immunisation with a Two-Dose Inactivated Hepatitis A Vaccine.
Antibody profile and isotypic patterns on HIV infected patients under drug treatment.
Antibody reactivities to p53 and HTLV-1 regulatory proteins- Tax, Rex and Tof in HTLV-I-infected people.
Antibody reactivity to envelope epitopes correlates with rate of HIV-1 disease progression.
Antibody reactivity to V3-based peptides in sera of mice immunized with baculovirus-derived rgp160.